Suven Pharmaceuticals

SUVENPHAR

₹ 643.90

- ₹ 1.75

-0.27%

Suven Pharmaceuticals
Market Sentiment

Timeline	Returns	Volume
Daily	-	-
Weekly	-4.20%	4,96,091
Monthly	4.59%	22,59,919

Suven Pharmaceuticals
Performance

DATA

CHART

Timeline	Daily	Weekly	Monthly
SUVENPHAR	-	-4.20%	4.59%
Index	-	-1.46%	-2.67%
Peer Avg.	-	-3.06%	-0.53%

*Avg of index constituents

Suven Pharmaceuticals
Fundamentals

DATA

CHART

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
SUVENPHAR	31.43	10.32	18.08	36.82	47.46	1.01
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	0.00	0.00	0.00	0.00	0.00	0.00

*Avg of index constituents

Suven Pharmaceuticals
Key Metrics

DATA

CHART

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	30.75%	57.27%	36.82	47.46
FY '20-21	21.10%	14.55%	31.94	37.67
FY '19-20	120.68%	146.57%	38.75	45.39

Suven Pharmaceuticals
Shareholding Pattern

Promoters : 60%

FII : 8.56%

DII : 6.56%

Public : 24.88%

Others : 0%

Suven Pharmaceuticals
Profit & Loss

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	1,320.22	738.22	722.09	485.40
FY '20-21	1,009.72	566.70	457.26	308.63
FY '19-20	833.79	449.02	402.89	269.43

All values are in crores

Suven Pharmaceuticals
Peer Comparison

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
SUVENPHAR	1,320.22	738.22	722.09	485.40
AEGISCHEM	2,929.48	2,499.17	580.95	418.42
KALYANKJIL	9,937.01	9,155.54	821.84	219.10

All values are in crores

Suven Pharmaceuticals
Similar Stocks

Glaxosmithkline Pharmaceuticals

GLAXO

₹ 1,972.30

- ₹ 3.60

-0.18%

Suven Pharmaceuticals Share Price

Suven Pharmaceuticals Limited is an Indian company. The company is engaged in the development and production of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals and formulated drugs as part of contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The company operates through a pharmaceutical manufacturing and service segment. Its geographic segments include India, the United States, Europe and others. In India, the company wholesales pharmaceuticals and intermediates, chemicals and services. In the United States, the company sells intermediate products and services. In Europe, the Company sells drugs and intermediates in bulk. In other countries, the Company wholesales medicines, intermediates and services. The company's wholly owned subsidiary is Suven Pharma Inc.

Suven Pharmaceuticals FAQs

How to Buy Suven Pharmaceuticals Share?

To purchase Suven Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Suven Pharmaceuticals (ticker symbol: suvenphar) on the trading platform provided by your broker and purchase the shares.

What's Suven Pharmaceuticals share price today?

The stock price of Suven Pharmaceuticals as of 10 May 2024 is ₹643.90

What is the Market Cap of Suven Pharmaceuticals?

Market capitalisation represents the total market value of a company's outstanding shares. As of 10 May 2024, Suven Pharmaceuticals (ticker symbol: suvenphar) has a market capitalisation of approximately ₹1,25,98,41,96,724.40

What is the PE and PB ratio of Suven Pharmaceuticals?

Suven Pharmaceuticals Ltd's price-to-book ratio as of 10 May 2024 is 10.322551, reflecting the market's valuation compared to its asset value. As of 10 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 31.425407, indicating the market values the company at around ₹31.43 for every ₹1 of earnings

What is the 52 Week High and Low of Suven Pharmaceuticals Share?

Suven Pharmaceuticals Ltd (suvenphar) hit its 52-week high at ₹768.00, and its 52-week low at { ₹469.45}.